Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 50,000 shares at $67.46 ($3.3M) on 2021-09-13, disclosed to the SEC on 2021-09-14.
Open-market sale of $3.3M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.94 | 15,809 | $1.0M | 31.5% |
| 2 | $65.94 | 15,809 | $1.0M | 31.5% |
| 3 | $66.84 | 8,391 | $561K | 16.9% |
| 4 | $66.84 | 8,391 | $561K | 16.9% |
| 5 | $67.46 | 800 | $54K | 1.6% |
| 6 | $67.46 | 800 |
| $54K |
| 1.6% |
| Total | $66.29 avg | 50,000 | $3.3M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |